Tradestie Institutional Equity Comparison Engine

AVDL vs JNJ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Momentum & Technical, Options & Structure while JNJ counters with relative strength in Growth & Margin. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus JNJ at 23.3x Forward P/E and 26.6% operating margin (+5.9% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against JNJ sits in CONSOLIDATION (45th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
AVDL 28.8x vs JNJ 23.3x Fwd P/E
Growth & Margin Winner JNJ
Op Margin 2.5% vs 26.6% ยท YoY +54.9% vs +5.9%
Momentum & Technical Winner AVDL
1Y +138.1% vs +33.6% ยท 52W Pos 89% vs 78%
Options & Structure Winner AVDL
UNCLASSIFIED (<1st %ile IV) vs CONSOLIDATION (45th %ile IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
JNJ NYSE
Johnson & Johnson
Pharmaceutical Preparations
$270.47
+1.25% 1D
Market Cap $643.1B
1M Return +1.07%
1Y Return +33.56%
Forward P/E 23.3x
Unified AI Score
57.8 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 66.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% JNJ +33.56% Spread: +25.26 pp (JNJ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% JNJ TTM Op. Margin: 26.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs JNJ. Trailing 12-month operating profitability (AVDL 2.5% vs JNJ 26.6%) and valuation multiples (AVDL 28.8x vs JNJ 23.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (5) vs JNJ (5)
Institutional Metric AVDL JNJ Criterion Row Winner
Market Capitalization Scale $2.1B $643.1B Larger Scale JNJ
Trailing P/E Ratio Valuation 16.8x 40.5x Lower Multiple AVDL
Forward P/E Ratio Valuation 28.8x 23.3x Lower Multiple JNJ
Revenue Growth (YoY) Growth +54.9% +5.9% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 26.6% Higher Margin JNJ
Net Profit Margin Profitability -0.1% 16.2% Higher Margin JNJ
Return on Equity (ROE) Capital Efficiency -0.3% 20.0% Higher ROE JNJ
52-Week Range Position Momentum 89% ($6โ€“$24) 78% ($199โ€“$290) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol -0.04ฮฒ ยท 25% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 57.8 / 100 (HOLD) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs JNJ Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
JNJ CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live JNJ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor JNJ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.